Guardian Pharmacy Services, Inc.
US ˙ NYSE

SecurityGRDN / Guardian Pharmacy Services, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership35,185 shares
Latest Disclosed Value $ 1,058,716
Barclays Plc reports 25.78% increase in ownership of GRDN / Guardian Pharmacy Services, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 35,185 shares of Guardian Pharmacy Services, Inc. (US:GRDN) valued at $1,058,717 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 27,973 shares of Guardian Pharmacy Services, Inc.. This represents a change in shares of 25.78% during the quarter. The current value of the position is $1,377,141 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F GUARDIAN PHARMACY SVCS COM 40145W101 35,185 7,212 25.78 1,059 44.34 0.0003
2026-03-31 2025-09-30 13F/A-3 GUARDIAN PHARMACY SVCS COM 40145W101 27,973 2,075 8.01 734 33.03 0.0002
2026-03-19 2025-09-30 13F/A-2 GUARDIAN PHARMACY SVCS COM 40145W101 18,500 -7,398 311 0.0001
2025-11-12 2025-09-30 13F GUARDIAN PHARMACY SVCS COM 40145W101 27,973 2,075 734 0.0002
2026-02-27 2025-06-30 13F/A-2 GUARDIAN PHARMACY SVCS COM 40145W101 25,898 16,964 189.88 552 191.53 0.0001
2025-08-14 2025-06-30 13F/A-1 GUARDIAN PHARMACY SVCS COM 40145W101 25,898 16,964 1 0.0001
2025-08-13 2025-06-30 13F GUARDIAN PHARMACY SVCS COM 40145W101 25,898 16,964 1 0.0000
2026-03-17 2025-03-31 13F/A-1 GUARDIAN PHARMACY SVCS COM 40145W101 8,934 -4,275 -32.36 190 -29.21 0.0001
2025-05-15 2025-03-31 13F GUARDIAN PHARMACY SVCS COM 40145W101 8,934 -4,275 0 0.0001
2026-03-19 2024-12-31 13F/A-1 GUARDIAN PHARMACY SVCS COM 40145W101 13,209 -5,291 -28.60 268 -13.87 0.0001
2025-02-13 2024-12-31 13F GUARDIAN PHARMACY SVCS COM 40145W101 13,209 -5,291 0 0.0001
2026-03-31 2024-09-30 13F/A-2 GUARDIAN PHARMACY SVCS COM 40145W101 18,500 18,500 311 0.0001
2024-11-19 2024-09-30 13F/A-1 GUARDIAN PHARMACY SVCS COM 40145W101 18,500 18,500 0 0.0001
2024-11-15 2024-09-30 13F GUARDIAN PHARMACY SVCS COM 40145W101 18,500 18,500 0 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.